Insiders · RCKT

RCKT insider transactions

Rocket Pharmaceuticals Inc. (RCKT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RCKT

• 11d
  SEC Form 4 filed by Officer Militello John

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 12d
  CEO Shah Gaurav exercised 76,490 shares at a strike of $1.69 and sold $171,841 worth of shares (55,684 units at $3.09), increasing direct ownership by 2% to 1,061,724 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 18d
  General Counsel Wilson Martin sold $1,995 worth of shares (662 units at $3.01), decreasing direct ownership by 0.10% to 677,977 units (SEC Form 4) to satisfy withholding tax

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 18d
  CEO Shah Gaurav sold $7,261 worth of shares (2,409 units at $3.01), decreasing direct ownership by 0.23% to 1,040,918 units (SEC Form 4) (withholding tax)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 18d
  Officer Militello John sold $1,157 worth of shares (384 units at $3.01), decreasing direct ownership by 0.43% to 89,780 units (SEC Form 4) (for tax liability)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 25d
  General Counsel Wilson Martin sold $12,120 worth of shares (3,361 units at $3.61), decreasing direct ownership by 0.49% to 678,639 units (SEC Form 4) (withholding tax)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 25d
  CEO Shah Gaurav sold $9,837 worth of shares (2,728 units at $3.61), decreasing direct ownership by 0.26% to 1,043,327 units (SEC Form 4) to cover taxes

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 25d
  Officer Militello John sold $3,083 worth of shares (855 units at $3.61), decreasing direct ownership by 0.94% to 90,164 units (SEC Form 4) to satisfy withholding tax

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 27d
  Officer Chaudhuri Sarbani sold $67,741 worth of shares (17,650 units at $3.84), decreasing direct ownership by 6% to 267,510 units (SEC Form 4) to cover taxes

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 108d
  Officer Militello John sold $3,862 worth of shares (1,157 units at $3.34), decreasing direct ownership by 1% to 91,019 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 108d
  CEO Shah Gaurav sold $19,995 worth of shares (5,990 units at $3.34), decreasing direct ownership by 0.57% to 1,046,055 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 108d
  General Counsel Wilson Martin sold $4,593 worth of shares (1,376 units at $3.34), decreasing direct ownership by 0.20% to 682,000 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 109d
  General Counsel Wilson Martin sold $40,582 worth of shares (12,253 units at $3.31), decreasing direct ownership by 2% to 683,376 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 109d
  Officer Militello John sold $12,341 worth of shares (3,726 units at $3.31), decreasing direct ownership by 4% to 92,176 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 109d
  CEO Shah Gaurav sold $40,668 worth of shares (12,279 units at $3.31), decreasing direct ownership by 1% to 1,052,045 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  CEO Shah Gaurav was granted 286,028 shares, increasing direct ownership by 37% to 1,064,324 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  Officer Militello John was granted 29,982 shares, increasing direct ownership by 45% to 95,902 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  General Counsel Wilson Martin was granted 311,813 shares, increasing direct ownership by 81% to 695,629 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  Chief Operating Officer Stevens Christopher James was granted 61,963 shares, increasing direct ownership by 15% to 469,129 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  Officer Chaudhuri Sarbani was granted 125,924 shares, increasing direct ownership by 79% to 285,160 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 115d
  Chief Medical Officer Rizvi Syed Ali-Aamir was granted 61,963 shares, increasing direct ownership by 18% to 407,874 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 153d
  Director Bjork Elisabeth bought $34,400 worth of shares (10,000 units at $3.44), increasing direct ownership by 25% to 50,000 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 200d
  CEO Shah Gaurav sold $18,721 worth of shares (6,276 units at $2.98), decreasing direct ownership by 0.80% to 778,296 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 200d
  Officer Schwartz Jonathan David sold $7,592 worth of shares (2,545 units at $2.98), decreasing direct ownership by 0.84% to 299,064 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 200d
  General Counsel Wilson Martin sold $4,910 worth of shares (1,646 units at $2.98), decreasing direct ownership by 0.43% to 383,816 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 200d
  Officer Militello John sold $3,240 worth of shares (1,086 units at $2.98), decreasing direct ownership by 2% to 65,920 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 210d
  General Counsel Wilson Martin was granted 100,000 shares, increasing direct ownership by 35% to 385,462 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 235d
  Officer Militello John sold $114,581 worth of shares (28,918 units at $3.96), decreasing direct ownership by 30% to 67,006 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 243d
  Chief Medical Officer Rizvi Syed Ali-Aamir was granted 345,911 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 247d
  Director Fong Peter was granted 53,333 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 247d
  SEC Form 3 filed by new insider Fong Peter

  3 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 258d
  SEC Form 4 filed by Director Rtw Investments, Lp

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 258d
  SEC Form 3 filed by new insider Rizvi Syed Ali-Aamir

  3 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 272d
  Officer Militello John was granted 40,000 shares, increasing direct ownership by 72% to 95,924 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 272d
  General Counsel Wilson Martin was granted 150,000 shares, increasing direct ownership by 111% to 285,462 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 272d
  Officer Schwartz Jonathan David was granted 80,000 shares, increasing direct ownership by 36% to 301,609 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 284d
  Director Bjork Elisabeth bought $34,100 worth of shares (10,000 units at $3.41), increasing direct ownership by 33% to 40,000 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 292d
  Officer Schwartz Jonathan David sold $7,561 worth of shares (2,485 units at $3.04), decreasing direct ownership by 1% to 221,609 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 292d
  Officer Militello John sold $3,224 worth of shares (1,060 units at $3.04), decreasing direct ownership by 2% to 55,924 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 292d
  CEO Shah Gaurav covered exercise/tax liability with 2,234 shares, decreasing direct ownership by 0.28% to 784,572 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 292d
  General Counsel Wilson Martin sold $4,839 worth of shares (1,592 units at $3.04), decreasing direct ownership by 1% to 135,462 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 294d
  Officer Militello John sold $21,263 worth of shares (7,043 units at $3.02), decreasing direct ownership by 11% to 56,984 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 294d
  Officer Schwartz Jonathan David sold $33,695 worth of shares (11,161 units at $3.02), decreasing direct ownership by 5% to 224,094 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 294d
  General Counsel Wilson Martin sold $36,557 worth of shares (12,109 units at $3.02), decreasing direct ownership by 8% to 137,054 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 306d
  Chief Operating Officer Stevens Christopher James was granted 407,166 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 308d
  SEC Form 3 filed by new insider Stevens Christopher James

  3 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Pratumsuwan Piratip was granted 30,000 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Wong Roderick was granted 47,667 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Makker Gotham was granted 49,434 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Granadillo Pedro P was granted 54,734 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Malik Fady Ibraham was granted 30,000 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Bjork Elisabeth was granted 30,000 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Dolsten Mikael was granted 30,000 shares, increasing direct ownership by 211% to 44,220 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Boess Carsten was granted 30,000 shares (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 325d
  Director Southwell David P was granted 30,000 shares, increasing direct ownership by 1,807% to 31,660 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 335d
  Chief Financial Officer Ondrey Aaron sold $4,257 worth of shares (1,477 units at $2.88), decreasing direct ownership by 1% to 128,173 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 382d
  Officer Patel Kinnari sold $4,944 worth of shares (767 units at $6.45), decreasing direct ownership by 0.17% to 441,927 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 382d
  Officer Schwartz Jonathan David sold $5,163 worth of shares (801 units at $6.45), decreasing direct ownership by 0.34% to 235,255 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 382d
  Officer Militello John sold $2,301 worth of shares (357 units at $6.45), decreasing direct ownership by 0.55% to 64,027 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)
• 382d
  CEO Shah Gaurav sold $14,523 worth of shares (2,253 units at $6.45), decreasing direct ownership by 0.29% to 786,806 units (SEC Form 4)

  4 - ROCKET PHARMACEUTICALS, INC. (0001281895) (Issuer)